Search

Search Constraints

You searched for: Author/Creator Lurie, Yoav

Search Results

4. HCV Genotype-1 Subtypes and Resistance-Associated Substitutions in Drug-Naive and in Direct-Acting Antiviral Treatment Failure Patients. Issue 5 (July 2017)

5. High Frequency of Multiclass HCV Resistance-Associated Mutations in Patients Failing Direct-Acting Antivirals: Real-Life Data. Issue 3 (April 2019)

6. IDDF2019-ABS-0136 Sofosbuvir/velpatasvir for 12 weeks is safe and effective in patients undergoing dialysis. (June 2019)

7. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019)

8. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019)

9. Sustained virological response with intravenous silibinin: individualized IFN‐free therapy via real‐time modelling of HCV kinetics. (10th October 2014)